129 related articles for article (PubMed ID: 25685658)
1. Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D.
Korrer MJ; Routes JM
Results Immunol; 2015; 5():1-5. PubMed ID: 25685658
[TBL] [Abstract][Full Text] [Related]
2. Possible role of arginase-1 in concomitant tumor immunity.
Korrer MJ; Zhang Y; Routes JM
PLoS One; 2014; 9(3):e91370. PubMed ID: 24614600
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
Routes JM; Ryan S; Morris K; Takaki R; Cerwenka A; Lanier LL
J Exp Med; 2005 Dec; 202(11):1477-82. PubMed ID: 16314433
[TBL] [Abstract][Full Text] [Related]
4. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A
Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945
[TBL] [Abstract][Full Text] [Related]
5. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
Routes JM; Ryan JC; Ryan S; Nakamura M
Int Immunol; 2001 Oct; 13(10):1301-7. PubMed ID: 11581175
[TBL] [Abstract][Full Text] [Related]
6. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
Miura TA; Cook JL; Potter TA; Ryan S; Routes JM
J Cell Biochem; 2007 Mar; 100(4):929-40. PubMed ID: 17063489
[TBL] [Abstract][Full Text] [Related]
7. E1A oncogene induced sensitization to NK cell induced apoptosis requires PIDD and Caspase-2.
Radke JR; Routes JM; Cook JL
Cell Death Discov; 2019; 5():110. PubMed ID: 31285853
[TBL] [Abstract][Full Text] [Related]
8. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
Routes JM; Ryan S; Li H; Steinke J; Cook JL
Virology; 2000 Nov; 277(1):48-57. PubMed ID: 11062035
[TBL] [Abstract][Full Text] [Related]
9. NKG2D function protects the host from tumor initiation.
Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
[TBL] [Abstract][Full Text] [Related]
12. Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.
Routes JM; Morris K; Ellison MC; Ryan S
J Virol; 2005 Jan; 79(1):116-23. PubMed ID: 15596807
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus E1A, not human papillomavirus E7, sensitizes tumor cells to lysis by macrophages through nitric oxide- and TNF-alpha-dependent mechanisms despite up-regulation of 70-kDa heat shock protein.
Miura TA; Morris K; Ryan S; Cook JL; Routes JM
J Immunol; 2003 Apr; 170(8):4119-26. PubMed ID: 12682242
[TBL] [Abstract][Full Text] [Related]
14. Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice.
Al Dulaimi D; Klibi J; Olivo Pimentel V; Parietti V; Allez M; Toubert A; Benlagha K
Front Immunol; 2018; 9():1052. PubMed ID: 29868013
[TBL] [Abstract][Full Text] [Related]
15. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
16. The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.
Talebian L; Fischer DA; Wu J; Channon JY; Sentman CL; Ernstoff MS; Meehan KR
Transfusion; 2014 Jun; 54(6):1515-21. PubMed ID: 24446786
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells.
Sawada Y; Föhring B; Shenk TE; Raska K
Virology; 1985 Dec; 147(2):413-21. PubMed ID: 3878030
[TBL] [Abstract][Full Text] [Related]
18. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
Maccalli C; Pende D; Castelli C; Mingari MC; Robbins PF; Parmiani G
Eur J Immunol; 2003 Jul; 33(7):2033-43. PubMed ID: 12884870
[TBL] [Abstract][Full Text] [Related]
19. Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis.
Kenyon DJ; Raska K
Virology; 1986 Dec; 155(2):644-54. PubMed ID: 2947382
[TBL] [Abstract][Full Text] [Related]
20. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]